We are live on ! Find out more
ADMA icon

ADMA Biologics
ADMA

91 hedge funds and large institutions have $140M invested in ADMA Biologics in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 14

170% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 10

41% more call options, than puts

Call options by funds: $1.99M | Put options by funds: $1.41M

23% more funds holding

Funds holding: 74 → 91 (+17)

8% more capital invested

Capital invested by funds: $130M → $140M (+$9.86M)

1.39% more ownership

Funds ownership: 54.73% → 56.11% (+1.4%)

Holders
91
Holders Change
+17
Holders Change %
+22.97%
% of All Funds
2.01%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
27
Increased
41
Reduced
14
Closed
10
Calls
$1.99M
Puts
$1.41M
Net Calls
+$583K
Net Calls Change
+$604K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$17.5M
2
BlackRock
BlackRock
New York
+$4.59M
3
6CM
683 Capital Management
New York
+$4.49M
4
SFM
Sphera Funds Management
Israel
+$4.49M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.31M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$6.17M
2
MWVC
Morgens Waterfall Vintiadis & Co
New York
-$2.4M
3
SSA
Schonfeld Strategic Advisors
New York
-$1.79M
4
Jane Street
Jane Street
New York
-$443K
5
Millennium Management
Millennium Management
New York
-$249K
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
76
ProShare Advisors
Maryland
$35K -$26.2K -7,579 -39%
PPA
77
Parametric Portfolio Associates
Washington
$32K -$27.3K -7,905 -41%
OC
78
Oppenheimer & Co
New York
$31K +$2.8K +810 +8%
Legal & General Group
79
Legal & General Group
United Kingdom
$30K +$1.16K +335 +3%
EAM
80
Evanson Asset Management
California
$29K +$34.6K +10,000 New
Bank of America
81
Bank of America
North Carolina
$27K -$29.1K -8,420 -47%
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$22K -$874 -253 -3%
CSS
83
Cubist Systematic Strategies
Connecticut
$18K +$21.1K +6,096 New
AIP
84
Ameritas Investment Partners
Nebraska
$12K – – –
ASN
85
Advisory Services Network
Georgia
$9K – – –
SF
86
Synovus Financial
Georgia
$9K +$10.4K +3,000 New
MAM
87
Meeder Asset Management
Ohio
$6K +$2.45K +710 +48%
US Bancorp
88
US Bancorp
Minnesota
$3K +$3.49K +1,009 New
SPIA
89
Steward Partners Investment Advisory
New York
$2K – – –
Daiwa Securities Group
90
Daiwa Securities Group
Japan
$1K – – –
SO
91
STRS Ohio
Ohio
$1K – – –
MWVC
92
Morgens Waterfall Vintiadis & Co
New York
– -$2.4M -600,000 Closed
CIBC World Market
93
CIBC World Market
Ontario, Canada
– -$152K -37,900 Closed
ARTA
94
A.R.T. Advisors
New York
– -$140K -35,029 Closed
GIM
95
Guild Investment Management
California
– -$105K -26,200 Closed
Two Sigma Investments
96
Two Sigma Investments
New York
– -$102K -25,453 Closed
Federated Hermes
97
Federated Hermes
Pennsylvania
– -$91K -22,825 Closed
SIM
98
Spark Investment Management
New York
– -$90K -22,500 Closed
AG
99
Algert Global
California
– -$70K -17,400 Closed
Two Sigma Advisers
100
Two Sigma Advisers
New York
– -$44K -11,000 Closed
1 2 3
4
5

ADMA Hedge Fund Activity: Q1 2020 in Review

91 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q1 2020, worth a combined $140M — up 7.6% from $130M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ADMA positions and 10 closed out — a net gain of 17 holders — while 41 added to existing stakes and 14 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $17.5M. The largest seller was Consonance Capital Management, cutting an estimated $6.17M.

  • 91 institutional investors held ADMA Biologics (ADMA) as of Q1 2020, up from 74 in Q4 2019.
  • Funds reported $140M of ADMA Biologics stock for Q1 2020, up 7.6% quarter-over-quarter.
  • 27 funds opened new ADMA Biologics positions in Q1 2020 and 10 closed out, a net change of +17 holders.
  • The largest ADMA Biologics buyer in Q1 2020 was Perceptive Advisors, an estimated $17.5M added.
  • The largest ADMA Biologics seller in Q1 2020 was Consonance Capital Management, an estimated $6.17M sold.

Based on aggregated 13F filings for Q1 2020.